2015
DOI: 10.4172/jbb.1000257
|View full text |Cite
|
Sign up to set email alerts
|

Scope of Nanotechnology in Drug Delivery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(6 citation statements)
references
References 46 publications
0
6
0
Order By: Relevance
“…And the second step involved preparation of paclitaxel Nanocochleate. I had prepared paclitaxel loaded Nanocochleates by trapping method (Webster, 2007;Maroof and Zafar, 2015).…”
Section: L3mentioning
confidence: 99%
“…And the second step involved preparation of paclitaxel Nanocochleate. I had prepared paclitaxel loaded Nanocochleates by trapping method (Webster, 2007;Maroof and Zafar, 2015).…”
Section: L3mentioning
confidence: 99%
“…Nanomedicine has been placing ahead several therapeutic principles that disrupt the manner we had been dealing with most cancers therapy, i.e. nanoparticles as drug shipping dealers, minimising side consequences and toxicity of the medicine [53] .…”
Section: In Drug Deliverymentioning
confidence: 99%
“…The utilization of particles in an extremely minute range helps to promote the properties and whole quality of the system. Particles existing in nanotechnology shows better attributes including, improved quality with a lower weight, protection from settling and decomposition, elevated saturation solubility state, enhanced drug absorption and release, increased adhesion to biological membranes, improved chemical reactivity, effective therapeutic action, improved bioavailability, and also decreasing side effects (Maroof et al, 2016; Sousa et al, 2019; Sultana et al, 2020).…”
Section: Introductionmentioning
confidence: 99%